No Data
Earnings Preview: SNDX to Report Financial Results Post-market on November 05
Syndax to Announce Third Quarter 2024 Financial Results and Host Conference Call and Webcast on November 5, 2024
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Viatris (VTRS) and Syndax Pharmaceuticals (SNDX)
UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
UBS Initiates Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Announces Target Price $37